Delivery Order SPE2DX22D0029-SPE2D826F08AA
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,909.80 to AmerisourceBergen Drug Corp on December 4, 2025, with an ultimate completion date of December 5, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supply fulfillment. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $31,361.72 to AmerisourceBergen Drug Corp on December 8, 2025, with an ultimate completion date of December 9, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the prime contractor for pharmaceutical and medical supply products to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $121,335.06 to AmerisourceBergen Drug Corp on December 8, 2025, with an ultimate completion date of December 9, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award under the company's existing indefinite delivery contract. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform work at its corporate office location and...
- The Defense Logistics Agency's Medical Supply Chain awarded a $46,475.04 delivery order to AmerisourceBergen Drug Corp on December 13, 2025, with an ultimate completion date of December 15, 2025. This competitively awarded, firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The delivery order will be performed at the contractor's...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $36,839.64 to AmerisourceBergen Drug Corp on November 10, 2025, with an ultimate completion date of November 12, 2025. This non-set-aside, firm fixed price delivery order represents a competitively awarded contract for pharmaceutical and medical supply delivery to support federal military healthcare requirements. The contract is being performed at AmerisourceBergen's corporate office location in...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $43,665.88 to AmerisourceBergen Drug Corp on November 17, 2025, with an ultimate completion date of November 18, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitively awarded contract for pharmaceutical and medical supply delivery to support federal military and healthcare systems. The work will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on December 6, 2025, for pharmaceutical and medical supply deliveries valued at $5,850.46. This firm fixed-price, competitively awarded delivery order is scheduled for completion by December 8, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania location. The award carries no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to compete...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $24,885.78 to AmerisourceBergen Drug Corp on December 11, 2025, with a completion date of December 12, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the prime contractor for pharmaceutical and medical supply distribution. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $66,973.11 to AmerisourceBergen Drug Corp on December 8, 2025, with an ultimate completion date of December 9, 2025. This firm fixed-price, non-set-aside delivery order (Contract No. 4570204693) represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. AmerisourceBergen, a major...
- The Defense Logistics Agency's Medical Supply Chain awarded a $111,668.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 8, 2025, with an ultimate completion date of December 9, 2025. This non-competitive delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.999 billion through December 2026. The company, headquartered in Conshohocken, Pennsylvania, will fulfill this order from...
- SPE2DX22D0029Indefinite Delivery Contract
- SPE2DX22D0029-SPE2D826F08AADelivery Order
The Defense Logistics Agency Medical Supply Chain awarded a $39,640.32 delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for pharmaceutical and medical supply products. The contract is structured as a firm fixed price delivery order with no set-aside designation, reflecting a competitive award to this major pharmaceutical distributor. The order is set to be completed by December 3, 2025, and will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a task issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC, designated as SPE2DX, serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products, including specialty medications, brand-name and generic drugs, vaccines, and medical devices to support military healthcare programs worldwide. AmerisourceBergen's established relationship with the DLA demonstrates its capability to fulfill federal medical procurement requirements across multiple therapeutic domains for Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $39.6k | 12/1/25 |